In our weekly expert view piece, Robert Finkel, CEO and lead strategist at Freshblood Health Market Consultants, takes a look at the concept of 'branded science' - a classic marketing and behavioral science technique - as a potent means of communication.
Words matter. Unlike the recent crop of awkward-sounding pharmaceutical brand names that convey an obscure meaning at best, new scientific terminology that defines emerging medical concepts needs to facilitate audience understanding.
I refer to this kind of specialized terminology as “Branded Science,” a method for applying classic marketing and behavioral science techniques to describe the pivotal technologies, mechanisms, or scientific concepts that accurately define a therapeutic product or category.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze